IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Polaris Venture Management Co. V, L.L.C.

Q1 2019 Holdings

Filed 2019-05-15 | 12 holdings | $118.2K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2019-06-28) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cardlytics, Inc.(CDLX)Common Stock14161W105$42.5K2,552,62635.9%
Fate Therapeutics, Inc.(FATE)ACommon Stock31189P102$25.9K1,473,18621.9%
Kala Pharmaceuticals, Inc.Common Stock483119103$15.4K1,857,58213.0%
Neuronetics, Inc.(STIM)ACommon Stock64131A105$11.3K742,2899.6%
Selecta Biosciences, Inc.(SELBUSD)ACommon Stock816212104$6.6K2,773,4795.6%
x4 Pharmaceuticals Inc(ASNSUSD)Common Stock98420X103$5.4K311,4924.6%
T2 Biosystems, Inc.Common Stock89853L104$4.8K1,841,9244.1%
Trevena, Inc.Common Stock89532E109$3.2K2,053,5402.7%
Genocea Biosciences, Inc.Common Stock372427104$1.2K1,968,6061.0%
Atyr Pharma Inc.(LIFEUSD)ACommon Stock002120103$1.0K1,827,9920.9%
Dare Bioscience, Inc.(CERUEUR)Common Stock23666P101$457326,2430.4%
Pulmatrix, Inc.ACommon Stock74584P103$456359,4380.4%